AbbVie interferon-free regimen cures 96% of treatment-experienced genotype 1 hepatitis C infections
Can we provide point-of-care viral load tests in poor countries?
PROUD UK PrEP study completes enrolment – first data give participants' background and risk factors
WHO recommends global use of newest hepatitis C drugs, urges price reductions